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Predictors of 1-Year Treatment Outcome in Bulimia Nervosa 
Cynthia M. Bulik, Patrick F. Sullivan, Peter R. Joyce, Frances A. Carter, and Virginia V. Mclntosh 
We examined predictors of outcome 1 year after 
completion of a randomized clinical trial assessing the 
additive efficacy of two forms of exposure with re- 
sponse prevention to a core of cognitive-behavioral 
therapy (CBT) for bulimia nervosa (BN}. One hundred 
one women who met DSM-III-R criteria for BN, and 
who completed the clinical trial, were available for 
follow-up at I year. Predictor variables were assessed 
prospectively and partitioned temporally to reflect 
lifetime history (including personality), pretreatment 
clinical status, and posttreatment clinical status. Out- 
come was based on the frequency of binging and 
purging in the 3 months before assessment based on 
carefully constructed lifechart interviews. A series of 
stepwise logistic regressions were performed to deter- 
mine independent predictors of 1-year outcome while 
controlling for treatment received. Demographic vari- 
ables were unrelated to treatment outcome. A history 
of obesity was predictive of poor outcome, whereas a 
history of alcohol dependence decreased the odds of 
poor outcome. High self-directedness on the Tempera- 
ment and Character Inventory (TCI) predicted favor- 
able outcome at  1 year, whereas personality disorder 
symptoms were not predictive. Pretreatment global 
functioning, bulimia scores on the Eating Disorders 
Inventory (EDI), and the presence of major depression 
predicted poor outcome. Posttreatment binging, food 
restriction, and urges to binge on a cue reactivity 
assessment predicted poor outcome at  1 year. The 
character trait of self-directedness is a strong predic- 
tor of good outcome for CBT, and methods to enhance 
this trait may be worthy of investigation. Low global 
functioning and the presence of major depression at  
presentation may require additional treatment than 
focused CBT for BN. Our results argue for treatment 
goals that include abstinence from binging and restrict- 
ing and decreases in urges to binge in response to 
high-risk cues. 
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I DENTIFICATION OF VARIABLES that pre- dict treatment outcome in women with bulimia 
nervosa (BN) is critical if we are to increase the 
degree of sophistication with which we treat the 
disorder. Understanding predictors of outcome could 
theoretically facilitate matching treatments to indi- 
viduals based on their clinical profiles at presenta- 
tion. Likewise, accurate prediction of clinical course 
based on status at the end of a circumscribed 
treatment could assist with treatment planning for 
individuals who are likely to relapse. 
Despite the increasingly large number of studies 
addressing the outcome of BN, little consensus has 
been reached regarding predictors of outcome (see 
Keel and Mitchell 1 for a review). Across studies, 
putative predictors of outcome have fallen into 
approximately seven categories: demography (age, 
socioeconomic status, marital status, and educa- 
tion); behavioral symptoms of the disorder (sever- 
ity of binging and purging and duration of illness); 
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psychological or cognitive features (body dissatis- 
faction and drive for thinness); axis I comorbidity; 
axis II comorbidity; associated personality or psy- 
chological characteristics (self-esteem and ineffec- 
tiveness); and family history (e.g., depression, 
alcoholism, and obesity). A replicable set of predic- 
tors of outcome has not yet been identified. 
Many studies have failed to account for the 
temporal nature of the predictor variables. Predic- 
tors often include items that are assessed at pretreat- 
ment about the past time frame (e.g., history of 
weight fluctuations or lifetime history of depres- 
sion), at pretreatment about the present time frame 
(e.g., frequency of pretreatment binging and purg- 
ing), and at the end of treatment about the present 
time frame (e.g., frequency of posttreatment bing- 
ing and purging). Determining the pretreatment 
characteristics of an individual that predict long- 
term outcome poses a very different question than 
examining the predictive capacity of posttreatment 
status. Examination of pretreatment variables ad- 
dresses characteristics of the treatment-seeking 
individual that are predictive of outcome, whereas 
examination of posttreatment variables addresses 
characteristics of the individual, characteristics of 
the treatment, and the individual-by-treatment inter- 
action. The first question is relevant to treatment 
matching, and the second is more relevant to 
stepped care and relapse prevention. 
The definition of outcome in the literature has 
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a l so  va r i ed .  D e f i n i t i o n s  h a v e  r a n g e d  f r o m  " n o  
l o n g e r  m e e t i n g  D S M - I I I - R  c r i t e r i a  fo r  B N "  to 
" a b s t i n e n t "  f r o m  b i n g i n g  a n d  p u r g i n g  fo r  a spec i -  
f ied  du ra t i on .  E a c h  o f  t h e s e  d e f i n i t i o n s  p o s e s  a 
u n i q u e  se t  o f  d i f f icu l t i es .  F o r  e x a m p l e ,  an  ind i -  
v idua l  n o  l o n g e r  m e e t i n g  c r i t e r i a  fo r  B N  c a n  st i l l  b e  
b i n g i n g  a n d  p u r g i n g  regula r ly .  S imi la r ly ,  g i v e n  tha t  
B N  is o f t e n  a w a x i n g  a n d  w a n i n g  c o n d i t i o n ,  2 
a b s t i n e n c e  c a n  b e  p r e c a r i o u s  i f  n o t  a s s e s s e d  o v e r  a 
su f f i c i en t ly  l o n g  in te rva l .  F ina l ly ,  c o m p l i c a t i n g  all 
a s s e s s m e n t  fo r  B N  is t h e  u n c e r t a i n  n a t u r e  o f  
s e l f - r e p o r t  a n d  t h e  a b s e n c e  o f  o b j e c t i v e  t e s t s  ve r i f y -  
i ng  c l in ica l  s ta tus .  
A l t h o u g h  t h e  c u r r e n t  i n v e s t i g a t i o n  c o u l d  n o t  
a d d r e s s  all  o f  t h e s e  i s sues ,  i ts  p r i m a r y  g o a l  w a s  to  
e x a m i n e  p r e d i c t o r s  o f  o u t c o m e  f r o m  B N  1 y e a r  
a f t e r  t h e  c o m p l e t i o n  o f  c o g n i t i v e - b e h a v i o r  t h e r a p y  
( C B T )  b y  p a r t i t i o n i n g  p r e d i c t o r s  t e m p o r a l l y  in to  
l i f e t i m e  ( i n c l u d i n g  p e r s o n a l i t y ) ,  p r e t r e a t m e n t ,  a n d  
p o s t t r e a t m e n t  c a t e g o r i e s .  
M E T H O D S  
Participants 
The data from this report are taken from the 1-year follow-up 
assessment of a randomized clinical trial examining the additive 
efficacy of two forms of exposure with response prevention to a 
core of CBT for the treatment of BN. Initial results from the 
clinical trial have been presented elsewhere. 3 Inclusion criteria 
for this study were female gender, age 17 to 45 years, and the 
presence of a current primary DSM-III-R diagnosis of BN. 
Exclusion criteria were current anorexia nervosa, current obe- 
sity (body mass index > 30 kg/m2), current severe major 
depression (including serious suicidal intent or inability to 
engage in cognitive therapy due to severity of depression), 
current severe medical illness or severe medical complications 
of BN, or current use of psychoactive medication and unwilling- 
ness to undergo a supervised drug wash-out period. Recruitment 
was broad-based and included direct mailings to general practi- 
tioners and mental health providers and advertisements at local 
universities, polytechnic institutes, and in local media. 
Procedure 
This study was approved by the Southern Regional Health 
Authority (Canterbury) and the University of Canterbury ethical 
committees. All participants signed written informed consent. 
Before treatment, participants underwent an extensive psychiat- 
ric and behavioral assessment. Data from this assessment are 
used in this report as the pretreatment predictors of 1-year 
outcome. The presence of axis I and II disorders were deter- 
mined with the Structured Clinical Interview for DSM-III-R 
([SCID] Patient version and version for Personality Disor- 
ders). 4,5 In addition, the assessing clinician completed a struc- 
tured clinical interview developed for this study and based on 
constructs outlined in the Eating Disorders Examination 6 to 
determine the frequency of objective binging (eating an unusu- 
ally large amount of food in a short period of time and feeling 
out of control), 7 frequency of purging (episodes of vomiting and 
laxative use), and intensity and frequency of body dissatisfac- 
tion and food restriction over the previous 2 weeks; the 
Hamilton Depression Rating Scale (HDRS)8; and the Global 
Assessment of Functioning Scale (GAFS). The clinician-rated 
body dissatisfaction and food restriction items were first com- 
bined to give an intensity × frequency index and then parti- 
tioned into quartiles. Participants also completed the Eating 
Disorders Inventory (EDI) 9 (drive for thinness, bulimia, and 
body dissatisfaction scales are reported herein) and the Tempera- 
ment and Character Inventory (TCI). 1° 
Before beginning treatment, a cue reactivity assessment was 
performed that examined physiological (heart rate and blood 
pressure), cognitive (urge to binge and urge to purge), and 
affective (subjective units of distress [SUDS]) responses to the 
presentation of individualized high-risk foods under controlled 
laboratory conditions. The procedure was standardized across 
all subjects for time of day and time since last meal. Before the 
assessment, subjects were given a complete description of the 
procedure, and a cue inventory was performed that identified 
"high-risk" foods that were most likely to trigger a binge. On 
the day of the cue reactivity assessment, after 10 minutes of 
baseline, a platter containing the highest risk food was brought 
into the room. The participant was asked to view, smell, and 
finally eat as much of the food as she could. Subjects reported 
their urge to binge, urge to purge, and SUDS at 2-minute 
intervals. Physiological and self-report recordings continued 
throughout the procedure. The food was removed after the 
subjects chose to discontinue eating (or after they made a finn 
decision not to eat). Recordings continued for approximately 10 
more minutes, after which subjects were appropriately de- 
briefed. The peak measures for the self-report ratings of urge to 
binge, urge to purge, and SUDS are examined in this report. 
Treatment Conditions 
All treatment was manual-based (treatment manuals are 
available for purchase by contacting the first author), and 
conducted by trained female clinical psychologists. All individu- 
als who entered the study first received eight sessions of CBT. 
For the first 2 weeks, sessions were twice weekly, followed by 
weekly sessions for 4 weeks. CBT consisted of self-monitoring, 
normalization of meals, psychoeducation, self-monitoring, cue 
identification, challenging automatic thoughts, thought restruc- 
turing, chaining, and relapse prevention. Specific goals for each 
session were outlined clearly in the manuals, and homework was 
assigned for each module. 
Participants were then randomized to either exposure with 
response prevention to prebinge cues (B-ERP), exposure with 
response prevention to prepurge cues (P-ERP), or a control 
condition of relaxation training. The nature of these treatments 
is described elsewhere in greater detail. 3 Briefly, in the B-ERP 
condition, individuals were exposed to cue combinations that 
preceded binge eating, did not actually eat any foods, and were 
prevented from engaging in the binge response. In the P-ERP 
condition, subjects were exposed to prepurge cue combinations, 
which included eating high-risk foods, and the purging response 
was prevented. Relaxation involved guided progressive deep- 
muscle relaxation exercises. Each of the experimental treat- 
ments included eight sessions over 6 weeks. All ERP and 
relaxation sessions were a minimum of 50 minutes; however, in 
the ERP conditions, exposure continued until physiological and 
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self-report measures approached baseline. Thus, although the 
number of sessions was equated across experimental treatments, 
the actual duration of sessions was longer in the ERP conditions 
than in relaxation treatment. 
Posttreatment Assessment and 6-Month 
Follow-up Status 
Following the last treatment session, all participants under- 
went a final posttreatment assessment with one of the authors 
(P.ES. or P.R.J.) who was blinded to treatment condition. This 
assessment consisted of the same structured interview for 
bulimic symptoms administered at pretreatment, the HDRS, 
GAFS, and EDI. In addition, the cue reactivity assessment was 
repeated at this time. 
Summarizing the results of the trial, there were no significant 
differences across the three behavioral treatments on the percent- 
age of individuals who were abstinent from binging or purging, 
or mean frequency of binging and purging at end-treatment. At 
the end of treatment, B-ERP, but not P-ERP, significantly 
reduced anxiety on the cue reactivity assessment, food restric- 
tion, body dissatisfaction, drive for thinness, and depression. 
These differences were not, however, maintained at the 6-month 
or 1-year follow-up evaluation) 
One- Year Follow-up 
One year after the completion of treatment, all participants 
were contacted for a face-to-face follow-up evaluation. The 
subject and the assessor developed a lifechart for the 6 months 
before the evaluation. We enhanced the accuracy of recall by 
anchoring the 2-week epochs to memorable events in the 
patient's life and by including information that had been 
obtained previously in a face-to-face interview 6 months earlier 
and in a telephone interview 3 months earlier. The lifechart 
divided the 6-month interval into 2-week epochs, and the 
frequency of objective binging and purging during each epoch 
was recorded. We then calculated the mean frequency of binging 
and purging per 2-week period in the 3 months before the 1-year 
follow-up to develop an index of outcome based on the core 
behavioral features of BN. This definition reflected the diagnos- 
tic thresholds in DSM-IV (i.e., binging and compensatory 
behaviors occurred, on average, a minimum of twice per week 
for 3 months). For the 3 months before follow-up, the outcome 
categories were as follows: (1) no binging or purging; (2) some 
binging and/or purging, but both not more than twice per week 
on average; and (3) binging and purging twice per week or more 
on average. 
Subject Flow and Follow-up 
Of the 135 women who began the clinical trial, 106 (78.5%) 
completed both the CBT and exposure/relaxation portions of the 
treatment. Of the 106 individuals who completed the treatment, 
12-month follow-up data were available for 101 women (95% of 
completers and 75% of starters), who comprise the subjects of 
this report. 
Data Analyses 
Putative predictor variables were determined a priori during 
the development of the assessment batteries for this study and 
were assessed prospectively. Predictors were divided into three 
categories as follows: variables assessed at pretreatment about 
lifetime history (including personality), variables assessed at 
pretreatment about pretreatment status, and variables assessed at 
posttreatment about clinical status at the end of the treatment 
trial. 
We first used univariate logistic regression 11,12 to compute the 
measures of association between the putative predictors and the 
dependent variable (the trichotomous variable reflecting binging 
and total episodes of purging averaged over the 3 months before 
the 1-year follow-up evaluation). Next, we used stepwise 
logistic regression (setting the probability level to enter and 
leave the model at .15) within each of the three classes of 
predictors to determine the most parsimonious combination of 
predictors. Because these data were from a randomized clinical 
trial and the 1-year outcome could thus be influenced by the 
different treatment each individual received, variables coding 
the treatment received were stipulated to remain in all stepwise 
logistic regressions. 
RESULTS 
Definition of Outcome 
Of the 101 women available for follow-up at 1 
year, 17% met DSM-III-R criteria for BN in the 
month before the 1-year follow-up assessment. 
Based on the frequency of binging and purging 
reported in the lifechart interviews in the 3 months 
before assessment, 38% of  the sample reported no 
binging and purging, 45% reported some binging 
and/or purging but not more than twice per week on 
average, and 16% reported binging and purging 
twice per week or more on average. These 16% 
corresponded to the 17% of women who met 
DSM-III-R criteria at follow-up, with the slight 
difference attributable to missing data on one 
patient. The percentages of  individuals in each 
outcome group who reported having received any 
additional treatment for their eating disorder in the 
interval between the end of treatment and the 
1-year follow-up assessment were 2.6% (no bing- 
ing or purging group), 6.7% (some binging and 
purging group), and 37.5% (twice per week or 
more group) (×2 = 12.1, P = .002). 
Treatment Group 
For each of the series of  logistic regressions, 
treatment group was entered as a fixed predictor 
variable, meaning that these variables were con- 
strained to remain in all regression models. In the 
lifetime and personality multivariate models, being 
randomized to the B-ERP treatment condition sig- 
nificantly decreased the odds of poor outcome at 1 
year (odds ratio [OR] = 0.32; 95% confidence 
interval [CI], 0.12 to 0.91). Treatment group did not 
independently predict outcome in either the pretreat- 
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ment or posttreatment multivariate regression analy- 
ses. 
Lifetime Variables Assessed at Pretreatment 
Table 1 presents univariate logistic regressions 
and stepwise multiple logistic regressions for the 
eight lifetime history, seven TCI, and three SCID-II 
variables assessed at pretreatment. None of the 
lifetime history variables significantly predicted 
outcome at 1 year in the univariate analyses. The 
TCI self-directedness scale significantly predicted 
outcome at 1 year with higher self-directedness 
associated with better outcome. For the cluster A 
(paranoid, schizoid, and schizotypal), cluster B 
(borderline, histrionic, narcissistic, and antisocial), 
and cluster C (obsessive-compulsive, dependent, 
avoidant, and passive-aggressive) symptom totals, 
none was significant in either the univariate or 
multivariate analyses. Given the interest in the 
literature in borderline personality disorder as a 
predictor of outcome, we conducted a univariate 
logistic regression using this personality disorder 
as the sole predictor. Borderline personality disor- 
der did not predict 1-year outcome (OR = 1.29, 
95% CI, 0.55 to 3.04). 
In the multivariate logistic regression, we en- 
tered all of the lifetime and personality variables as 
predictors. A lifetime history of obesity increased 
the odds of poor outcome by 7.9; a lifetime history 
of alcohol dependence decreased the odds of poor 
outcome by 0.26; and for each unit increase on the 
self-directedness scale, the odds of poor outcome 
were decreased by 0.94. 
Pretreatment Status 
Table 2 presents the eight clinician-rated vari- 
ables, three self-report variables, and three mea- 
sures of cue reactivity that reflected clinical status 
at pretreatment. In the univariate analyses, lower 
GAFS, higher EDI bulimia scores, greater peak 
self-report urge to binge ratings on the cue reactiv- 
ity assessment, and current major depression pre- 
dicted poorer outcome at 1 year. In the multivariate 
analyses, GAFS, EDI bulimia, and major depres- 
sion in the past month were retained in the stepwise 
procedure as significant independent predictors of 
Table 1. Prediction of 1-Year Treatment Outcome of BN With Univariate and Stepwise Logistic Regression Using Variables 
With Demographics, Lifetime History, and Personality as Predictors 
Mean (SD) Univariate Logistic Regression Stepwise Logistic Regression 
Lifetime Variables* or % OR CI OR CI 
Age (yr) 26.5 (6.13) 0.97 0.91-1.03 ¢ 
BMI minimum (kg/m 2) 18.6 (2.46) 0.95 0.81-1.10 $ 
History of obesity (BMI >30) 8.8% 2.60 0.71-9.56 7.86 
Prior inpatient treatment 9.9% 1.04 0.30-3.57 $ 
Duration of BN (yr) 6.82 (6.07) 0.96 0.91-1.03 
Lifetime anorexia nervosa 24.3% 1.09 0.46-2.60 $ 
Lifetime major depression 52.5% 1.15 0.55-2.41 ¢ 
Lifetime alcohol dependence 42.6% 0.81 0.38-1.72 0.26t 
Lifetime anxiety disorder§ 43.6% 1.21 0.57-2.56 $ 
Novelty seeking 21.6 (6.33) 1.0O 0.94-1.06 $ 
Harm avoidance 20.7 (6.89) 1.03 0.98-1.09 ~t 
Reward dependence 15.8 (4.36) 1.03 0.95-1.12 
Persistence 4.82 (1.98) 1.06 0.88-1.29 
Self-directedness 24.5 (8.20) 0.94* 0.89-0.98t 0.92t 
Cooperativeness 34.1 (5.77) 1.01 0.95-1.08 
Self-transcendence 11.1 (5.66) 1.00 0.94-1.07 
Total cluster A symptoms 4.12 (3.45) 1.02 0.91-1.14 $ 
Total cluster B symptoms 7.35 (4.96) 1.07 0.99-1.16 $ 




Abbreviation: BMI, body mass index. 
*Dependent variable: outcome 0, no binging or purging; 1, intermediate binging or purging; 2, binging and purging > 2x/wk for 3 
months. Treatment group fixed in all analyses. Receiving B-ERP was significantly and independently predictive of outcome at 1 year 
in these analyses. 
tlndicates significance at the c~ < .05 level. 
SVariable excluded in stepwise analysis. 
§Includes generalized anxiety disorder, social phobia, and obsessive-compulsive disorder; excludes simple phobia. 
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Table 2. Prediction of 1-Year Treatment Outcome of BN With Onivariate and Stepwise Logistic Regression Using Variables 
With Pretreatment Status as Predictors 
Univariate Logistic Regression Stepwise Logistic Regression 
Pretreatment Status Mean (SD) or % OR CI OR CI 
Binges per 2-week period 
Total purges per 2-week period 
Food restriction (quartiles) 
Body dissatisfaction (quartiles) 
GAFS 
HDRS 
EDI: drive for thinness 
EDh bulimia 
EDI: body dissatisfaction 
SUDS 
urge to binge 
P , ~  urge to purge 
Major depression--past mo 
Alcohol dependence--past mo 
10.6 (11.5) 1.03 0.99-1.06 $ 
14.7 (20.8) 1.03 1.00-1.06 $ 
3: 24% 
2: 29% 





0.97 0.64-1.49 0.67 
1 : 24% 
O: 4% 
55.6 (6.66) 0.91t 0.86-0.97t 0.931" 
8.75 (5.39) 1.07 0.99-1.15 $ 
14.3 (4.64) 1.09 1.00-1.19 $ 
9.61 (4.78) 1.151" 1.05-1.25t 1.16t 
18.9 (7.50) 1.03 0.98-1.08 $ 
1.67 (0.83) 1.45 0.68-3.12 $ 
2.44 (0.50) 1.68 1.05-2.69 $ 
2.04 (0.95) 1.34 0.89-1.98 ~t 
23% 3.54t 1.39-9.01t 2.80t 





*Dependent variable: outcome 0, no binging or purging; 1, intermediate binging or purging; 2, binging and purging >2x /wk  for 3 
Treatment months. Treatment group fixed in all analyses (see text for further details). 
tlndicates significance at the c~ = .05 level. 
SVariable excluded in stepwise analysis. 
§Includes generalized anxiety disorder, social phobia, and obsessive-compulsive disorder; excludes simple phobia. 
outcome. For each unit increase on the GAFS, the 
odds of good outcome increased by 0.93. For each 
unit increase on the EDI bulimia scale, the odds of 
poor outcome increased by 1.16. Finally, the pres- 
ence of major depression at pretreatment increased 
the odds of poor outcome by 2.80. 
Posttreatment Status 
In the univariate analyses, several of the post- 
treatment variables significantly predicted 1-year 
outcome (Table 3). Poor outcome was predicted by 
the following: greater number of binges during the 
final 2-week period; greater food restriction; greater 
body dissatisfaction; lower GAFS; higher HDRS 
scores; higher EDI drive for thinness and bulimia 
scores; and higher peak SUDS, urge to binge, and 
urge to purge on the cue reactivity assessment. In 
the multivariate analyses, a greater number of 
binges per 2-week period, greater food restriction, 
and higher peak urge to binge on the cue reactivity 
assessment at the end of treatment independently 
predicted poorer outcome. In terms of magnitude of 
the effect, for each additional binge per 2-week 
period, the odds of poor outcome increased by 1.23. 
For food restriction, our variable was coded in 
terms of quartiles; thus, for each increase in quartile 
that reflected an increase of intensity and/or fre- 
quency, the risk of poor outcome increased by a 
factor of 2.35. 
DISCUSSION 
The primary aim of this study was to examine 
the prospective predictors of outcome 1 year after a 
clinical trial of CBT in 101 women with BN. We 
chose a definition of outcome anchored in the core 
behavioral features of the disorder (i.e., binging 
and purging), which reflected DSM-1V diagnostic 
thresholds and which was derived via a careful 
lifechart interview that reconstructed the individu- 
al's symptoms of BN in the 3-month interval before 
the 1-year follow-up assessment. 
The Effect of Treatment Received 
Given this was a randomized clinical trial, we 
fixed the variables that defined treatment group 
(i.e., B-ERP, P-ERP) to remain in the regression 
analyses. In the stepwise multivariate regression 
examining lifetime history variables, the odds of a 
favorable outcome at 1 year were increased if an 
individual had been assigned to B-ERP. B-ERP did 
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Table 3. Prediction of One-Year Outcome of Bulimia Nervosa With Univariate and Stepwise Logistic Regression Using Variables 
Reflecting Posttreatment Status as Predictors 
Univariate Logistic Regression Stepwise Logistic Regression 
Posttreatment Variables* Mean (SD) or % OR CI OR CI 
Binges per 2-week period 
Total purges per 2-week period 
Food restriction (quartiles) 
Body dissatisfaction (quartiles) 
GAFS 
HDRS 
EDI: drive for thinness 
EDI: bulimia 
EDI: body dissatisfaction 
P ~  SUDS 
~ u r g e  to binge 
~ u r g e  to purge 
1.58 (3.24) 1.30t 1.11-1.51t 1.23t 1.06-1.42t 
3.67 (8.03) 1.10 1.03-1.18 $ 
3: 5% 
2: 15% 
2.45t 1.52-3.96t 2.35t 1.38-4.01t 




3.25t 1,89-5.58t $ 
1: 52% 
0: 13% 
69.6 (9.85) 0.90t 0,86-0.95t 
5.15 (5.64) 1.11t 1.04-1.20t $ 
6.69 (6.08) 1.15t 1.07-1.24t ¢ 
2.23 (3.26) 1.23t 1.09-1.40t :1: 
11.9 (8.22) 1.05 1.00-1.10 :1: 
1.68 (0.83) 1.79t 1.09-2.94t ¢ 
0.79 (0.92) 2.11 t 1.34-3.34t 2.06t 1.24-3.43t 
0.80 (0.98) 2.81t 1.76-4.47t $ 
*Dependent variable: outcome O, no binging or purging; 1, intermediate bJnging or purging; 2, binging and purging >2x /wk  for 3 
months. Treatment group fixed in all analyses. 
tlndicates significance at the ct = .05 level. 
SVariable excluded in stepwise analysis. 
not emerge as a significant predictor in either the 
pretreatment or posttreatment regressions, suggest- 
ing the magnitude of the effect is not sufficiently 
large when considering other more robust predic- 
tors. This finding reflects the results of the clinical 
trial wherein B-ERP was associated with positive 
outcome at the end of treatment with a fading effect 
at 6 months and 1 year. 
Lifetime History and Personality 
In terms of the lifetime history and personality 
predictors, a history of obesity increased the odds 
of poor outcome, and both a history of alcohol 
dependence and high self-directedness on the TCI 
decreased the odds of poor outcome. We did not 
find any predictive effect of duration of illness, 
unlike other studies that have found longer duration 
to be predictive of either poor outcome 13-15 (suggest- 
ing that more entrenched behaviors are more diffi- 
cult to change) or the opposite ~6 (suggesting that 
individuals who have suffered from the disorder for 
longer are more motivated to change). We were 
also unable to detect a curvilinear relationship 
between length of illness and outcome. 
A history of obesity increased the odds of poor 
outcome by 7.9 (95% CI, 1.42 to 43.6). Our 
findings are similar to those of Maddocks and 
Kaplan, 17 who found that poor responders tended to 
have a higher highest past weight than treatment 
responders. It is likely that having a history of 
obesity perpetuates dietary restriction, which in our 
subsequent analyses, was also predictive of poor 
outcome at I year. 
Of our lifetime axis I comorbidity predictors, 
only alcohol dependence significantly predicted 
outcome. A lifetime diagnosis of anorexia nervosa, 
major depression, or any anxiety disorder (exclud- 
ing simple phobia) did not significantly predict how 
an individual would fare at 1 year posttreatment. In 
contrast, a lifetime history of alcohol dependence 
actually decreased the odds of poor outcome. This 
finding is consistent with Strasser et al., 18 who 
found that bulimic women with prior substance 
abuse had significantly lower posttreatment scores 
on self-reports of eating symptomatology, were 
more responsive to treatment, and displayed a 
better response to desipramine than bulimic women 
with no such history. Given that both of these 
studies examined past substance abuse or depen- 
dence, it is possible that success in overcoming one 
disorder is predictive of success in overcoming 
another. 
The effect of personality disorders, especially 
borderline personality disorder, on treatment out- 
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come in BN has been the subject of much debate. 
Several studies have found borderline personality 
disorder, borderline tendencies, or cluster B charac- 
teristics to be associated with poor outcome. 1539-22 
This finding has not been universally replicated. 23 
In the present study, neither cluster B symptoms 
nor borderline personality disorder were significant 
predictors in either the univariate or multivariate 
analyses. In contrast, higher self-directedness, as- 
sessed by the TCI, was associated with superior 
outcome in both the univariate and multivariate 
regressions. 
Cloninger et al. 24 define self-directedness as a 
developmental process that encompasses several 
distinct aspects, including acceptance of responsi- 
bility for one's own choices, identification of 
individually valued goals and purposes, resourceful- 
ness, and self-acceptance. Indeed, such characteris- 
tics appear to capture the optimal characteristics 
necessary for success in CBT. The presence of 
self-directedness at pretreatment may be a power- 
ful predictor of suitability and treatment outcome in 
CBT. In a previous study, we found that self- 
directedness predicted the presence of personality 
disorder in women with BN. 25 We argued that 
self-directedness, as measured by the TCI, may 
encapsulate succinctly a construct fundamental to 
the concept of "personality disorder." It may be 
this type of a unitary dimensional construct that 
predicts poor outcome rather than the presence or 
absence of more multifaceted construct of personal- 
ity disorder. Self-directedness, but not personality 
disorder, has also been found to predict antidepres- 
sant response in individuals with major depression 
(P. Joyce, Personal Communication, August 1997). 
In light of these findings, the modifiability of the 
degree of self-directedness by the usefulness of 
techniques, such as motivational enhancement 
therapy 26 or techniques to enhance readiness for 
change, z7 remains an important empirical question. 
Pretreatment Clinical Status 
In the multivariate logistic regressions, lower 
global functioning, higher self-report bulimia scores 
on the EDI, and current major depression all 
increased the odds of having a poor outcome at 1 
year. This finding is important for treatment plan- 
ning. First, it appears that those individuals who, by 
the judgement of the clinician, are functioning 
more poorly across a host of domains, will do less 
well with CBT in the long run. Individuals with 
uncomplicated BN, who are functioning well in 
both social and occupational domains, may fare 
better with a focused short-term treatment. For 
individuals with lower global functioning, it may 
be necessary to embed CBT for BN into a more 
comprehensive treatment package to address the 
breadth of clinical problems. 
Second, unlike the actual frequency of binging 
and purging at pretreatment, severity of self-report 
bulimic symptoms and attitudes on the EDI was an 
independent predictor of outcome at 1 year. Whereas 
the actual frequency of binging and purging often 
waxes and wanes in women with BN, the EDI 
self-report may be a better indicator of the more 
stable underlying construct of bulimic pathology. It 
could also reflect the degree to which an individu- 
al's bulimic symptoms are incorporated into her 
self-concept. 
Finally, the odds of poor outcome were increased 
threefold in individuals who presented with major 
depression at pretreatment. This finding is consis- 
tent with several, 17,28-3° but not all studies. 23,31-33 
One strength of our study is that depression at 
pretreatment was assessed with a structured diagnos- 
tic instrument rather than self-report scales. It is 
possible that the neurovegetative symptoms associ- 
ated with depression interfere with engagement in 
the relatively focused and rapid-paced CBT in the 
clinical trial. Although not testable with this design, 
this finding could argue for the concurrent antide- 
pressant treatment of individuals with BN who 
present with major depression to enhance utiliza- 
tion or efficacy of CBT. 34 
Posttreatment Clinical Status 
The last series of analyses addressed whether 
there are features of the clinical status at the end of 
a therapeutic trial of CBT that can predict outcome 
at 1 year. This question is informative in several 
ways. First, it can highlight important symptoms to 
target during treatment. For example, in our study, 
the presence of binging behavior at the end of 
treatment presaged poor outcome. For each addi- 
tional binge per 2-week period, the odds of poor 
outcome at 1 year increased by 1.23. These findings 
support the assertion of Maddocks et al.3s that 
abstinence is a critical dimension of outcome. 
Similarly, if an individual continued to have a 
restrictive pattern of eating at the end of treatment, 
or if she continued to have a strong urge to binge in 
response to high-risk foods, her odds of poor 
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outcome were similarly increased. Thus,  absti- 
nence  from binging,  e l iminat ion  of restrictive eat- 
ing pat tems (i.e., dieting), and decreases in cue 
reactivity (especially urge to binge)  are important  
therapeutic goals to achieve before te rminat ion  of 
treatment. 
These results must  be interpreted with several 
caveats in mind.  First, the validity of  any regression 
analysis  hinges on  the choice of predictors. Al- 
though we at tempted to be pars imonious  in our  
choices, this still resulted in a relat ively large 
n u m b e r  of  putat ive predictor  variables. Variables 
that we did not  include could have had superior 
predictive capacity. Second, our results are specific 
for CBT, and the same set of  predictors may not  
significantly predict outcome for other types of 
psychotherapy or for pharmacological  treatment.  
Third, by choice, these analyses focused only on 
those individuals  who engaged in  t reatment  and 
who were available for fol low-up.  These predictors 
have no bear ing on determining who is l ikely to 
remain  in t reatment  versus d iscont inuing  prema- 
turely. 
In summary,  the presence of  impaired global  
funct ioning,  high self-report bu l imia  on the EDI, 
and current  major  depression should alert c l inicians 
that a narrow focused approach to the t reatment  of 
BN may not  be sufficient to address the range of 
clinical problems,  and that more  broad-based,  pos- 
sibly mul t imodal  t reatment  may  be opt imal  for 
these individuals  to ensure long- term posi t ive out- 
come.  Second, individuals  with a history of  obesity 
may  be at r isk for poor outcome,  whereas a history 
of alcohol dependence  may portend success. Third, 
the personal  quali ty of self-directedness may  be a 
strong indicator  of  readiness and abili ty to change 
at pretreatment .  Approaches  to enhance  self- 
directedness may  assist with augment ing  the effect 
of  CBT for individuals  who are low on this 
d imension.  Finally,  the results of  this study support  
the therapeutic goal of  abst inence from b ing ing  and 
dieting behavior  and a reduct ion in the urge to 
b inge  in response to high risk cues, as the presence 
of these features at the end of t reatment  is associ- 
ated with poor long- term outcome. Treatment  that 
is terminated before these behaviors  have been 
controlled may compromise  long- term recovery. 
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